Robin Kramer - Feb 5, 2025 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director
Signature
/s/ Robin Kramer
Stock symbol
ARMP
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
2/7/2025, 04:18 PM
Previous filing
Dec 9, 2024
Next filing
Feb 10, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +54.3K $0.00 54.3K Feb 5, 2025 Common Stock 54.3K $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date.